These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 9724739)

  • 1. MEKK1/JNK signaling stabilizes and activates p53.
    Fuchs SY; Adler V; Pincus MR; Ronai Z
    Proc Natl Acad Sci U S A; 1998 Sep; 95(18):10541-6. PubMed ID: 9724739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JNK targets p53 ubiquitination and degradation in nonstressed cells.
    Fuchs SY; Adler V; Buschmann T; Yin Z; Wu X; Jones SN; Ronai Z
    Genes Dev; 1998 Sep; 12(17):2658-63. PubMed ID: 9732264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jun NH2-terminal kinase phosphorylation of p53 on Thr-81 is important for p53 stabilization and transcriptional activities in response to stress.
    Buschmann T; Potapova O; Bar-Shira A; Ivanov VN; Fuchs SY; Henderson S; Fried VA; Minamoto T; Alarcon-Vargas D; Pincus MR; Gaarde WA; Holbrook NJ; Shiloh Y; Ronai Z
    Mol Cell Biol; 2001 Apr; 21(8):2743-54. PubMed ID: 11283254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin induces the proapoptotic conformation of Bak in a deltaMEKK1-dependent manner.
    Mandic A; Viktorsson K; Molin M; Akusjärvi G; Eguchi H; Hayashi SI; Toi M; Hansson J; Linder S; Shoshan MC
    Mol Cell Biol; 2001 Jun; 21(11):3684-91. PubMed ID: 11340162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of p19(ARF) with Mdm2 inhibits ubiquitin ligase activity of Mdm2 for tumor suppressor p53.
    Honda R; Yasuda H
    EMBO J; 1999 Jan; 18(1):22-7. PubMed ID: 9878046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stabilization of Mdm2 via decreased ubiquitination is mediated by protein kinase B/Akt-dependent phosphorylation.
    Feng J; Tamaskovic R; Yang Z; Brazil DP; Merlo A; Hess D; Hemmings BA
    J Biol Chem; 2004 Aug; 279(34):35510-7. PubMed ID: 15169778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stability.
    Buschmann T; Minamoto T; Wagle N; Fuchs SY; Adler V; Mai M; Ronai Z
    J Mol Biol; 2000 Jan; 295(4):1009-21. PubMed ID: 10656807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mechanism of geranylgeraniol-induced apoptosis involves activation, by a caspase-3-like protease, of a c-jun N-terminal kinase signaling cascade and differs from mechanisms of apoptosis induced by conventional chemotherapeutic drugs.
    Masuda Y; Nakaya M; Aiuchi T; Hashimoto S; Nakajo S; Nakaya K
    Leuk Res; 2000 Nov; 24(11):937-50. PubMed ID: 11086177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of cyclooxygenase-2 by the activated MEKK1 --> SEK1/MKK4 --> p38 mitogen-activated protein kinase pathway.
    Guan Z; Buckman SY; Pentland AP; Templeton DJ; Morrison AR
    J Biol Chem; 1998 May; 273(21):12901-8. PubMed ID: 9582321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p38 Mitogen-activated protein kinase mediates hypoxic regulation of Mdm2 and p53 in neurons.
    Zhu Y; Mao XO; Sun Y; Xia Z; Greenberg DA
    J Biol Chem; 2002 Jun; 277(25):22909-14. PubMed ID: 11948180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear Localization Signal and p53 Binding Site in MAP/ERK Kinase Kinase 1 (MEKK1).
    Chipps E; Protzman A; Muhi MZ; Ando S; Calvet JP; Islam MR
    J Cell Biochem; 2015 Dec; 116(12):2903-14. PubMed ID: 26018553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mdm2 association with p53 targets its ubiquitination.
    Fuchs SY; Adler V; Buschmann T; Wu X; Ronai Z
    Oncogene; 1998 Nov; 17(19):2543-7. PubMed ID: 9824166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of apoptosis by low dose stress stimuli in cells expressing activated MEK kinase 1.
    Widmann C; Johnson NL; Gardner AM; Smith RJ; Johnson GL
    Oncogene; 1997 Nov; 15(20):2439-47. PubMed ID: 9395240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axin forms a complex with MEKK1 and activates c-Jun NH(2)-terminal kinase/stress-activated protein kinase through domains distinct from Wnt signaling.
    Zhang Y; Neo SY; Wang X; Han J; Lin SC
    J Biol Chem; 1999 Dec; 274(49):35247-54. PubMed ID: 10575011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of apoptosis by alpha-subunits of G12 and G13 proteins via apoptosis signal-regulating kinase-1.
    Berestetskaya YV; Faure MP; Ichijo H; Voyno-Yasenetskaya TA
    J Biol Chem; 1998 Oct; 273(43):27816-23. PubMed ID: 9774391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mast cell tumor necrosis factor alpha production is regulated by MEK kinases.
    Ishizuka T; Terada N; Gerwins P; Hamelmann E; Oshiba A; Fanger GR; Johnson GL; Gelfand EW
    Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6358-63. PubMed ID: 9177222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of the ATF2 transcription factor is regulated by phosphorylation and dephosphorylation.
    Fuchs SY; Tappin I; Ronai Z
    J Biol Chem; 2000 Apr; 275(17):12560-4. PubMed ID: 10777545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytoprotective aminothiol WR1065 activates p53 through a non-genotoxic signaling pathway involving c-Jun N-terminal kinase.
    Pluquet O; North S; Bhoumik A; Dimas K; Ronai Z; Hainaut P
    J Biol Chem; 2003 Apr; 278(14):11879-87. PubMed ID: 12531896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective activation of the c-Jun N-terminal kinase (JNK) pathway fails to elicit Bax activation or apoptosis unless the phosphoinositide 3'-kinase (PI3K) pathway is inhibited.
    Molton SA; Todd DE; Cook SJ
    Oncogene; 2003 Jul; 22(30):4690-701. PubMed ID: 12879014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The kinase domain of MEKK1 induces apoptosis by dysregulation of MAP kinase pathways.
    Boldt S; Weidle UH; Kolch W
    Exp Cell Res; 2003 Feb; 283(1):80-90. PubMed ID: 12565821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.